Charge Detection Mass Spectrometry Reveals Conformational Heterogeneity in Megadalton-Sized Monoclonal Antibody Aggregates
Journal of the American Chemical Society · 21.08.2024 · 146 (33) · 23297-23305
DOI: 10.1021/jacs.4c05885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 07.08.2024. Verfasst von Jacob S Jordan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Berkeley, California 94720-1460, United States. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Mass Spectrometry, Protein Conformation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Division of Chemistry, Arnold and Mabel Beckman Foundation.
Abstract (Originalsprache)
Aggregation of protein-based therapeutics can occur during development, production, or storage and can lead to loss of efficacy and potential toxicity. Native mass spectrometry of a covalently linked pentameric monoclonal antibody complex with a mass of ∼800 kDa reveals several distinct conformations, smaller complexes, and abundant higher-order aggregates of the pentameric species. Charge detection mass spectrometry (CDMS) reveals individual oligomers up to the pentamer mAb trimer (15 individual mAb molecules; ∼2.4 MDa) whereas intermediate aggregates composed of 6-9 mAb molecules and aggregates larger than the pentameric dimer (1.6 MDa) were not detected/resolved by standard mass spectrometry, size exclusion chromatography (SEC), capillary electrophoresis (CE-SDS), or by mass photometry. Conventional quadrupole time-of-flight mass spectrometry (QTOF MS), mass photometry, SEC, and CE-SDS did not resolve partially or more fully unfolded conformations of each oligomer that were readily identified using CDMS by their significantly higher extents of charging. Trends in the charge-state distributions of individual oligomers provides detailed insight into how the structures of compact and elongated mAb aggregates change as a function of aggregate size. These results demonstrate the advantages of CDMS for obtaining accurate masses and information about the conformations of large antibody aggregates despite extensive overlapping m/z values. These results open up the ability to investigate structural changes that occur in small, soluble oligomers during the earliest stages of aggregation for antibodies or other proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.
- Discovery Biologics, Protein Sciences, Merck & Co., Inc., 213 E Grand Ave., South San Francisco, California 94080, United States.
ORCID-Profile: Jacob S Jordan, Evan R Williams
Förderung
- NIGMS NIH HHS
- Division of Chemistry
- Arnold and Mabel Beckman Foundation
- National Institute of General Medical Sciences
- Eli Lilly and Company
- Merck
Zitieren
APA
Jordan, J. S., Harper, C. C., Zhang, F., Kofman, E., Li, M., Sathiyamoorthy, K., Zaragoza, J. P., Fayadat-Dilman, L., & Williams, E. R. (2024). Charge Detection Mass Spectrometry Reveals Conformational Heterogeneity in Megadalton-Sized Monoclonal Antibody Aggregates. Journal of the American Chemical Society, 146(33), 23297-23305. https://doi.org/10.1021/jacs.4c05885
Vancouver
Jordan JS, Harper CC, Zhang F, Kofman E, Li M, Sathiyamoorthy K, et al. Charge Detection Mass Spectrometry Reveals Conformational Heterogeneity in Megadalton-Sized Monoclonal Antibody Aggregates. Journal of the American Chemical Society. 2024;146(33):23297-23305. doi:10.1021/jacs.4c05885
BibTeX
@article{Jordan2024,
author = {Jordan, Jacob S and Harper, Conner C and Zhang, Fan and Kofman, Esther and Li, Mandy and Sathiyamoorthy, Karthik and Zaragoza, Jan Paulo and Fayadat-Dilman, Laurence and Williams, Evan R},
title = {Charge Detection Mass Spectrometry Reveals Conformational Heterogeneity in Megadalton-Sized Monoclonal Antibody Aggregates},
journal = {Journal of the American Chemical Society},
year = {2024},
volume = {146},
number = {33},
pages = {23297--23305},
doi = {10.1021/jacs.4c05885}
}
EUVIMED